Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
641,937
-
Shares change
-
-411,761
-
Total reported value, excl. options
-
$3,369,033
-
Value change
-
-$2,182,064
-
Number of buys
-
2
-
Number of sells
-
4
-
Price
-
$5.25
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q4 2022
As of 31 Dec 2022 Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 641,937 shares of stock of the company.
Largest 8 holders included COMPASS GROUP LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, UBS Group AG, FNY Investment Advisers, LLC, MORGAN STANLEY, and CITADEL ADVISORS LLC.
This table shows 8 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.